inHEART
PrivateLast Round
Series A
Extension
Oct 28, 2024
Total Funding Raised
$16.21M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
inHEART operates in Healthcare & Life Sciences and is based in Bordeaux. Its latest recorded funding round was a Series A Extension round in October 2024.
inHEART is a medical technology company that provides an AI-powered, cloud-based software solution to create 3D digital twins of a patient's heart from medical images, enabling cardiologists to better plan and execute cardiac procedures.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
inHEART Comparables
Compare inHEART with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ADAS3D Medical | 88% | |
| Galgo Medical | 81% | |
| Volta Medical | 80% |
For institutional investors. Book with your work email.
inHEART Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 28, 2024 | ||||
| Early Funding | May 6, 2024 | ||||
| Grant | Jan 18, 2024 | ||||
| Seed | Jul 2, 2020 | ||||
| Grant | Jul 6, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
inHEART Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elaia Partners | Early Funding, Seed |
| Ministry of Higher Education and Research | Grant |
| Tudigo | Early Funding |
| Webit Foundation | Grant |
| Vesalius Biocapital Partners | Early Funding |
| Cleverage Venture Capital | Early Funding |
| SAGANA | Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 244% MoM, reaching 2K.
- Jan 8, 2026
Monthly visitors increased 31% MoM.
For institutional investors. Book with your work email.
inHEART Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about inHEART's valuation, stock price, and market status.
Is inHEART a public or private company?
inHEART is a private company.
What is the current stock price of inHEART?
inHEART is a private company, so its shares have no public market price. Caplight tracks inHEART's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is inHEART worth (valuation)?
Valuation information for inHEART is not publicly available.
Can I buy inHEART stock?
inHEART shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was inHEART's last funding round?
inHEART's most recent funding round was Series A Extension on October 28, 2024.
Who are the main investors in inHEART?
Key investors in inHEART include Elaia Partners, Webit Foundation, Vesalius Biocapital Partners.
Will inHEART IPO soon?
No public IPO plans have been announced for inHEART.
How can I track inHEART secondary market activity?
Caplight tracks bids, offers, and trades in inHEART's shares on secondary markets.